Research / AMSF / Fundamental state Inspectable configuration
State dimensions Filing 0001193125-26-314074 Insurance
Cash 100th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.cash
$65.5M · CORE · VALID
Policy-benefit growth 100th Own-history percentile · N=9
Evidence method Yoy · gp.insurance.policy_benefits
18.89% · OPTIONAL · VALID
Net-income growth 78th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.net_income
4.59% · CORE · VALID
Premium growth 100th Own-history percentile · N=9
Evidence method Yoy · gp.insurance.premiums
11.37% · CORE · VALID
Revenue growth 100th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.revenue
13.42% · CORE · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 10 states History building
Mar 31, 2024 0/5 normalized Level 3 Jun 30, 2024 0/5 normalized Level 3 Sep 30, 2024 0/5 normalized Level 3 Dec 31, 2024 0/5 normalized Level 3 Mar 31, 2025 1/5 normalized Level 3 Jun 30, 2025 1/5 normalized Level 3 Sep 30, 2025 1/5 normalized Level 3 Dec 31, 2025 1/5 normalized Level 3 Mar 31, 2026 5/5 normalized Level 3 Jun 30, 2026 5/5 normalized Level 3 Period transition
What moved in the state? Cash Increased
Previous $34.2M
Current $65.5M
Delta $31.3M Claims Growth Increased
Previous 15.64%
Current 18.89%
Delta 3.25% Earnings Growth Increased
Previous -8.98%
Current 4.59%
Delta 13.57% Premium Growth Increased
Previous 8.98%
Current 11.37%
Delta 2.39% Revenue Growth Increased
Previous 10.32%
Current 13.42%
Delta 3.10% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.